244 related articles for article (PubMed ID: 19780977)
1. In vitro interactions between amphotericin B and other antifungal agents and rifampin against Fusarium spp.
Spader TB; Venturini TP; Cavalheiro AS; Mahl CD; Mario DN; Lara VM; Santurio J; Alves SH
Mycoses; 2011 Mar; 54(2):131-6. PubMed ID: 19780977
[TBL] [Abstract][Full Text] [Related]
2. In vitro synergisms obtained by amphotericin B and voriconazole associated with non-antifungal agents against Fusarium spp.
Venturini TP; Rossato L; Spader TB; Tronco-Alves GR; Azevedo MI; Weiler CB; Santurio JM; Alves SH
Diagn Microbiol Infect Dis; 2011 Oct; 71(2):126-30. PubMed ID: 21840673
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
Li L; Wang Z; Li R; Luo S; Sun X
Am J Ophthalmol; 2008 Nov; 146(5):724-8. PubMed ID: 18707669
[TBL] [Abstract][Full Text] [Related]
4. In vitro interactions of antifungal agents against clinical isolates of Fusarium spp.
Córdoba S; Rodero L; Vivot W; Abrantes R; Davel G; Vitale RG
Int J Antimicrob Agents; 2008 Feb; 31(2):171-4. PubMed ID: 18054469
[TBL] [Abstract][Full Text] [Related]
5. Rifampin Enhances the Activity of Amphotericin B against Fusarium solani Species Complex and Aspergillus flavus Species Complex Isolates from Keratitis Patients.
He Y; Zhou L; Gao C; Han L; Xu Y
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115342
[TBL] [Abstract][Full Text] [Related]
6. In vitro interactions of licensed and novel antifungal drugs against Fusarium spp.
Ortoneda M; Capilla J; Javier Pastor F; Pujol I; Guarro J
Diagn Microbiol Infect Dis; 2004 Jan; 48(1):69-71. PubMed ID: 14761725
[TBL] [Abstract][Full Text] [Related]
7. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.
Marangon FB; Miller D; Giaconi JA; Alfonso EC
Am J Ophthalmol; 2004 May; 137(5):820-5. PubMed ID: 15126145
[TBL] [Abstract][Full Text] [Related]
8. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods.
Alastruey-Izquierdo A; Cuenca-Estrella M; Monzón A; Mellado E; Rodríguez-Tudela JL
J Antimicrob Chemother; 2008 Apr; 61(4):805-9. PubMed ID: 18263569
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility patterns of Aspergillus and Fusarium species isolated from equine ulcerative keratomycosis cases in the midwestern and southern United States with inclusion of the new antifungal agent voriconazole.
Pearce JW; Giuliano EA; Moore CP
Vet Ophthalmol; 2009; 12(5):318-24. PubMed ID: 19751493
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of clinical isolates of Fusarium to antifungal drugs.
Speeleveld E; Gordts B; Van Landuyt HW; De Vroey C; Raes-Wuytack C
Mycoses; 1996; 39(1-2):37-40. PubMed ID: 8786755
[TBL] [Abstract][Full Text] [Related]
11. Synergysm of voriconazole or itraconazole with other antifungal agents against species of Fusarium.
Spader TB; Venturini TP; Rossato L; Denardi LB; Cavalheiro PB; Botton SA; Santurio JM; Alves SH
Rev Iberoam Micol; 2013; 30(3):200-4. PubMed ID: 23402831
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
[TBL] [Abstract][Full Text] [Related]
13. Do antibacterial and antifungal combinations have better activity against clinically relevant fusarium species? in vitro synergism.
Venturini TP; Al-Hatmi AMS; Rossato L; Azevedo MI; Keller JT; Weiblen C; Santurio JM; Alves SH
Int J Antimicrob Agents; 2018 May; 51(5):784-788. PubMed ID: 29127050
[TBL] [Abstract][Full Text] [Related]
14. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
[TBL] [Abstract][Full Text] [Related]
15. Antifungal drug combinations for Cryptococcus neoformans and Prototheca spp.
Srimuang S; Prariyachatigul C; Chaiprasert A; Rungsipanuratn W; Tanphaichitra D
J Med Assoc Thai; 2000 Jan; 83(1):57-60. PubMed ID: 10710870
[TBL] [Abstract][Full Text] [Related]
16. In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs.
Drogari-Apiranthitou M; Mantopoulou FD; Skiada A; Kanioura L; Grammatikou M; Vrioni G; Mitroussia-Ziouva A; Tsakris A; Petrikkos G
J Antimicrob Chemother; 2012 Aug; 67(8):1937-40. PubMed ID: 22535624
[TBL] [Abstract][Full Text] [Related]
17. In vitro resistance of clinical Fusarium species to amphotericin B and voriconazole using the EUCAST antifungal susceptibility method.
Taj-Aldeen SJ; Salah H; Al-Hatmi AM; Hamed M; Theelen B; van Diepeningen AD; Boekhout T; Lass-Flörl C
Diagn Microbiol Infect Dis; 2016 Aug; 85(4):438-43. PubMed ID: 27312690
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of amphotericin B, itraconazole, voriconazole, posaconazole, caspofungin and terbinafine against Scytalidium dimidiatum and Scytalidium hyalinum clinical isolates.
Lacroix C; de Chauvin MF
J Antimicrob Chemother; 2008 Apr; 61(4):835-7. PubMed ID: 18218642
[TBL] [Abstract][Full Text] [Related]
19. Fusarium spp. as agents of onychomycosis in immunocompetent hosts.
Guilhermetti E; Takahachi G; Shinobu CS; Svidzinski TI
Int J Dermatol; 2007 Aug; 46(8):822-6. PubMed ID: 17651164
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of voriconazole against yeasts, moulds and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin.
Wildfeuer A; Seidl HP; Paule I; Haberreiter A
Arzneimittelforschung; 1997 Nov; 47(11):1257-63. PubMed ID: 9428984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
